Planet Green Holdings (PLAG) targets Chinese lactoferrin market with new Chief Scientist role
Rhea-AI Filing Summary
Planet Green Holdings Corp. entered into commercial operations to source, market and distribute lactoferrin, a glycoprotein used in health products including its chewable immune tablets. Lactoferrin is also used in infant formula, sports nutrition, and various dietary and immune supplements.
The company plans to expand its executive team by adding a Chief Scientist role to help direct scientific investments, joint ventures and new product launches aimed at broadening its product portfolio and revenue-generating capabilities. A candidate from a leading U.S. academic institution has been identified and the company is in advanced negotiations but no appointment has been made as of the report date.
The company highlights the Chinese lactoferrin market as its primary target, noting China represents 22% of an estimated $300 million global market and imports most lactoferrin due to limited domestic production.
Positive
- None.
Negative
- None.
8-K Event Classification
Key Figures
Key Terms
lactoferrin medical
glycoprotein medical
bioactive ingredient medical
forward-looking statements regulatory
Private Securities Litigation Reform Act of 1995 regulatory
FAQ
What new business has Planet Green Holdings (PLAG) entered according to this 8-K?
How does Planet Green Holdings (PLAG) plan to support its new lactoferrin business?
Has Planet Green Holdings (PLAG) filled the new Chief Scientist role yet?
What market is Planet Green Holdings (PLAG) targeting for its lactoferrin products?
How large is the global lactoferrin market mentioned by Planet Green Holdings (PLAG)?
What product does Planet Green Holdings (PLAG) already sell that uses lactoferrin?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
| (Exact name of registrant as specified in its charter) |
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including
area code: (
| Not Applicable |
| (Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01 Regulation FD Disclosure
On August 11, 2026, Planet Green Holdings Corp. (the “Company”) issued a press release announcing that it had entered into commercial operations to source, market and distribute lactoferrin for health-product applications.
The press release also states that the Company intends to expand its executive team by adding a Chief Scientist role to support scientific investments, joint ventures and new product launches. The Company has identified a candidate for this position; however, no appointment has been made as of the date of this Current Report.
A copy of the press release is attached as Exhibit 99.1 to this Current Report and is incorporated herein by reference.
The information furnished under this Item 7.01, including the press release attached as Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No. | Description | |
| 99.1 | Press Release dated August 11, 2026, titled “Planet Green Enters the Fast Growing Global Lactoferrin Market, Adding Chief Scientist to Drive Innovation-Based Product Portfolio Growth.” | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| Dated: August 13, 2026 | PLANET GREEN HOLDINGS CORP. | |
| By: | /s/ Bin Zhou | |
| Name: | Bin Zhou | |
| Title: | Chief Executive Officer and Chairman | |
2
Exhibit 99.1
Planet Green Enters the Fast Growing Global Lactoferrin Market,
Adding Chief Scientist to Drive Innovation-Based
Product Portfolio Growth
Company Gains Access to Rare and Commercially Desirable High-Quality
Lactoferrin for the Large and Rapidly Scaling Chinese Markets,
Adding New Scientist to Drive New Product Development
NEW YORK, August 11, 2026 /PRNewswire/ -- Planet Green Holdings Corp. (NYSE American: PLAG) (the “Company”), operating a diversified portfolio of businesses, including consumer products and online advertising, today announced it has entered into commercial operations to source, market and distribute lactoferrin, a critical glycoprotein used in a wide range of health products, including the Company’s chewable immune tablets. Lactoferrin is also widely used in infant formulas, sports nutrition, and a wide range of dietary and immune supplements.
To improve access to this fast-growing market, the Company intends to expand its executive team to include a Chief Scientist. This newly added role will play a key role in sourcing and prioritizing strategic scientific investments, joint ventures and new product launches with a goal to expand and enhance the Company’s product portfolio and revenue generating capabilities. The Company has identified a strong leading candidate at a leading US academic institution for this Chief Scientist role and is in advanced negotiations to fill the role in the near term.
Today, commercially produced lactoferrin is produced primarily through two methods:
| ● | Extraction from Bovine Milk (dominant method): |
| o | Whey or skim milk from traditional dairy processing is highly purified using membrane filtration and ion-exchange chromatography to isolate bovine lactoferrin. |
| o | Because milk contains relatively little lactoferrin, very large volumes of milk are required, making production expensive and supply constrained. |
| ● | Precision fermentation (emerging): |
| o | Genetically engineered microorganisms (such as yeast or fungi) produce recombinant lactoferrin in fermentation tanks. |
| o | This approach offers greater scalability, consistency, and potentially lower costs, although commercial adoption is still in its early stages. |
The Company is focused on delivering world class products that require the highest quality lactoferrin for the Chinese market. The target market is currently the world’s largest lactoferrin market, representing 22% of the estimated $300 million in annual global demand today. The market is expanding rapidly, at an estimated 9% annually, and is expected to exceed $100 million in annual sales in China alone by 2030 and $500 million globally. China imports almost all lactoferrin today, due primarily to limited domestic production capabilities.
The Company’s Chief Executive Officer, Zhou Bin commented on the importance of this critical compound in the global health markets, “Lactoferrin is a crucial glycoprotein that is part of your body’s immune response and is the hero ingredient in our chewable immune tablets. With our rapidly growing market share and consumer adoption, gaining access to this critical ingredient should only enhance our market position going forward.”
“Lactoferrin is obtained from mammalian milk, and has been dubbed “Pink Gold”, not only due to its pale pink hue, but also because of its extremely high commercial value. Extracting lactoferrin from cow’s milk is a complex and costly process, and the low yield and high demand make it a valuable and sought after bioactive ingredient.”
“We use pure lactoferrin which is unavailable in China for most of manufacturers and is expected to command a premium due to its high-quality. With a large market growing quickly to well over $100 million addressable market, we see this as attracting and compelling business opportunity for many years to come,” concluded Mr. Zhou.
About Planet Green Holdings Corp.
Planet Green Holdings Corp. (“Planet Green”), headquartered in Flushing, New York, is a Nevada holding company with business operations conducted through its subsidiaries in mainland China and Canada. Planet Green operates a diversified portfolio of businesses, including consumer products and online advertising.
2
Forward Looking Statements
This news release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “anticipate”, “believe”, “expect”, “estimate”, “plan”, “outlook”, and “project” and other similar expressions that indicate future events or trends or are not statements of historical matters. These statements are based on our management’s current expectations and beliefs, as well as a number of assumptions concerning future events. Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside of our control and all of which could cause actual results to differ materially from the results discussed in the forward-looking statements. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Factors that could cause actual results to differ materially from those expressed or implied in forward-looking statements can be found in our reports filed with the Securities and Exchange Commission, which are available, free of charge, on the SEC’s website at www.sec.gov.
For further information, please contact:
Ms. Wei Li
Chief Financial Officer
Phone: 347 370 2352
Email: weili@planetgreenholdings.com
3